IL-1β

Advertisement

cGxPJobs Banner

AC Immune Advances NLRP3 Inhibitor ACI-19764 in Phase 1

LAUSANNE, Switzerland, August 20, 2026 AC Immune SA announced positive preliminary Phase 1 clinical data for ACI-19764, its wholly...

By cGxPwire Editor
August 21, 2026

Read More

Advertisement

cGxPJobs

Directory